Dana-Farber’s Breast Oncology Center

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
January, 2025
January 2025
M T W T F S S
 12345
6789101112
13141516171819
20212223242526
2728293031  

Dana-Farber’s Breast Oncology Center
Jan 19, 2025, 07:17 | Science
Abemaciclib Plus Fulvestrant in Advanced Breast Cancer
Dana-Farber’s Breast Oncology Center posted on X, about recent paper by Kevin Kalinsky et al.,…
Jan 17, 2025, 22:17 | Insight
Abstracts are being accepted for the annual Dana-Farber/Harvard Cancer Center Breast and Gynecologic Cancer Symposium
Dana-Farber’s Breast Oncology Center shared a post on X: “Abstracts are now being accepted for…
Jan 15, 2025, 17:18 | Blog
Registration is open for the Research Updates and Advances in Brain Mets webinar - Dana-Farber’s Breast Oncology Center
Dana-Farber’s Breast Oncology Center shared a post on X: "Join Dana Farber's Nancy Lin, MD…
Jan 11, 2025, 11:08 | Blog
Dana-Farber’s Breast Oncology Center - Adrienne Waks receives the George P. Canellos Award for Excellence in Clinical Investigation
Dana-Farber’s Breast Oncology Center shared on X: "Congratulations to Adrienne Waks, Associate Director of Clinical…
Jan 9, 2025, 12:43 | Science
Is Preventative Oophorectomy Safe?
Dana-Farber’s Breast Oncology Center shared a recent article by Megan E. Tesch on X: "Check…
Jan 8, 2025, 17:12 | Blog
The use of Cold Caps in preventing Hair Loss with novel Breast Cancer therapies - Dana-Farber’s Breast Oncology Center
Dana-Farber’s Breast Oncology Center shared a post on X: “Dana-Farber’s Breast Oncology Center is leading…
Dec 26, 2024, 15:50 | Insight
Breast Cancer Research Digest by Dana-Farber’s Breast Oncology Center
Dana-Farber’s Breast Oncology Center shared a post on X: “Here’s the most recent Breast Cancer…
Dec 18, 2024, 13:50 | Blog
Proinflammatory Dietary Pattern and Risk of Total and Subtypes of Breast Cancer Among U.S. Women
Dana-Farber’s Breast Oncology Center shared on X: "New Study: Proinflammatory Dietary Pattern and Risk of Total…
Dec 17, 2024, 05:49 | Science
Breast Cancer Research Digest by Dana-Farber’s Breast Oncology Center
Dana-Farber’s Breast Oncology Center posted on X: "Check out the newest Breast Cancer Research Digest…
Dec 15, 2024, 08:38 | Blog
EMBER3 data in the context of other treatment options in ET-pretreated HR+/HER2- MBC
Paolo Tarantino, Working towards a PhD in clinical research at the University of Milan, shared…
Dec 14, 2024, 17:00 | Insight
Insights on PATINA trial from SABCS 2024
Pre-clinical data showed that CDK 4/6 inhibition plays a role in HER2+ disease. Phase 2…
Dec 14, 2024, 06:34 | Blog
Immediate Subsequent lines of therapy after T-DXd in Metastatic Breast Cancer - Dana-Farber’s Breast Oncology Center
Dana-Farber’s Breast Oncology Center shared a post on X: "SABCS24 POSTER SESSION | P1-08-08 |…
Dec 13, 2024, 20:25 | Blog
Olga Kantor: Financial toxicity in young women with breast cancer at SABCS24
Olga Kantor, Breast Surgeon at Brigham and Women's Hospital, shared a post on X: “Important…
Dec 12, 2024, 20:39 | Blog
Ada Waks on the management of small HER2+ breast cancers
Paolo Tarantino shared on X: "Terrific talk on the management of small HER2+ breast cancers by…
Dec 11, 2024, 16:46 | Blog
Sara Tolaney: Start early, it takes lots of time
Dana-Farber’s Breast Oncology Center posted on X: "Dr. Sara Tolaney offered great tips and strategies for…
Dec 11, 2024, 16:25 | Blog
Guilherme Nader-Marta at the SABCS24 Poster Spotlight Session 2 - Dana-Farber’s Breast Oncology Center
Dana-Farber’s Breast Oncology Center shared on X: “Join Dr. Guilherme Nader-Marta at the SABCS24 Poster…
Dec 11, 2024, 09:20 | Blog
Meet Dr. Stefania Morganti - Dana-Farber’s Breast Oncology Center
Dana-Farber’s Breast Oncology Center shared a post on X: "Meet Dr. Stefania Morganti, an Advanced…
Dec 8, 2024, 06:53 | Insight
The role of ADCs in the treatment of patients with Breast Cancer Brain Metastases - Dana-Farber’s Breast Oncology Center
Dana-Farber’s Breast Oncology Center shared a post on X, about a recent paper by Stacey…
Nov 29, 2024, 15:31 | Insight
Thanksgiving Day 2024: A Time for Gratitude and Reflection
Thanksgiving Day in 2024 fell on November 28th. Thanksgiving Day is a national holiday celebrated…
Nov 26, 2024, 17:58 | Blog
Dana-Farber’s Breast Oncology Center is leading a phase 2 study called TRUDI
Dana-Farber’s Breast Oncology Center shared a post on X: “We are leading a phase 2…
Nov 21, 2024, 15:07 | Insight
Consumption of aspartame and the risk of Breast Cancer in the Nurses' Health Studies
Dana-Farber’s Breast Oncology Center shared a post on X: “New study in JNCI from Dana-Farber’s…
Nov 18, 2024, 21:55 | Blog
Caterina Sposetti: New Oncologists from the University of Milan
Caterina Sposetti, Medical Oncology Fellow at Dana-Farber’s Breast Oncology Center and Dana-Farber Zakim Center, shared…
Nov 15, 2024, 17:45 | Insight
Osteopontin as a therapeutic target in Breast Cancer recurrence
A recent paper by Yu Gu, PhD Candidate at McGill University, was mentioned by Dana-Farber’s…
Nov 12, 2024, 18:59 | Insight
Dana-Farber’s Breast Cancer Research Digest
Dana-Farber’s Breast Oncology Center shared a post on X: "Here’s the Breast Cancer Research Digest…
Nov 11, 2024, 18:23 | Blog
Patient Insights on Recurrence in Hormone Receptor-Positive Breast Cancer - Dana-Farber’s Breast Oncology Center
Dana-Farber’s Breast Oncology Center shared a recent article by Shoshana M Rosenberg on X: "New article…
Nov 10, 2024, 16:37 | Insight
Incorporation of immunotherapy in the management of early-stage ER+ Breast Cancer
A recent paper by Guilherme Nader-Marta, Clinical Fellow at Dana-Farber Cancer Institute, was mentioned by…
Nov 10, 2024, 03:48 | Insight
Tracing 40 years of breakthroughs and challenges in ADC development
Dana-Farber’s Breast Oncology Center shared a post on X: “Don't miss this recently published Cancer…
Nov 8, 2024, 04:47 | Insight
ICIs for patients with metastatic triple-negative Inflammatory Breast Cancer
Dana-Farber’s Breast Oncology Center shared a post on X: “This just published international cohort study…
Nov 6, 2024, 14:55 | Insight
Dana Farber Cancer Institute’s 7th Annual Inflammatory Breast Cancer Patient Forum
Dana-Farber’s Breast Oncology Center shared a post on X: “Join us on Saturday November 9…
Nov 5, 2024, 01:27 | Career
Ashley Odai-Afotey to Research Health Equity in Cancer Pain Management and a Weight Loss intervention - Dana-Farber’s Breast Oncology Center
Dana-Farber’s Breast Oncology Center shared a post on X: "Meet Dr. Ashley Odai-Afotey, an Olney/Silver…
Nov 3, 2024, 09:27 | Blog
Ilana Schlam: Excited to kick off my first day at Dana-Farber’s Breast Oncology Center
Ilana Schlam posted on X: "Excited to kick off my first day at Dana-Farber’s Breast…
Oct 29, 2024, 13:05 | Insight
Paolo Tarantino: My 100th scientific publication
Paolo Tarantino, Fellow at Dana-Farber Cancer Institute, shared a post on X: "It turns out…
Oct 25, 2024, 11:48 | Blog
Paolo Tarantino: Anticipated evolutions in the assessment of MRD to guide cancer treatment
Paolo Tarantino shared a post on X: ''ENASymp24 day 3: Heather Parsons from Dana-Farber’s Breast…
Oct 17, 2024, 05:56 | Blog
Jun Mao: Amazing integrative medicine medical consult model of care Dana-Farber’s Breast Oncology Center
Jun Mao, Professor of Medicine at Weill Cornell Medicine, shared a post on X: “Seeing…
Oct 15, 2024, 19:00 | Insight
The use of TDXd for patients with Metastatic, HER2-low and HER2-ultralow Breast Cancer - Dana-Farber’s Breast Oncology Center
Dana-Farber’s Breast Oncology Center shared a post on X: "Check out our newest treatment guideline…
Oct 14, 2024, 11:40 | Insight
Characteristics and clinical outcomes of Breast Cancer in young BRCA carriers
Dana-Farber’s Breast Oncology Center shared a post on X: “New study now out in ESMO…
Oct 12, 2024, 12:43 | Blog
The 7th Annual B-PREP Patient Forum - Dana-Farber’s Breast Oncology Center
Dana-Farber’s Breast Oncology Center shared a post on X: "Join us on Sat, Oct 19th, 9…
Oct 12, 2024, 00:58 | Blog
SIO partner with Dana Farber Cancer Institute in hosting the 22nd SIO International Conference
Society for Integrative Oncology (SIO) shared on X: '' Save the date! SIO is excited to…
Oct 10, 2024, 09:30 | Blog
Elia Seguí, a new Advanced Fellow at the Dana-Farber’s Breast Oncology Center
Dana-Farber’s Breast Oncology Center shared a post on X: "Meet Dr. Elia Seguí, a new Advanced…
Oct 6, 2024, 16:57 | Blog
Sarah Sammons: Sound advice on how to help a friend with cancer
Sarah Sammons shared a post on X: "I am very lucky to know Renée and she…
Oct 4, 2024, 10:15 | Blog
The first prospective trial of sacituzimab govitecan (+ trastuzumab) after T-DXd for HER2+ MBC
Paolo Tarantino shared a post by Dana-Farber’s Breast Oncology Center on X, adding: "There’s few open questions as…
Oct 2, 2024, 14:56 | Insight
The most recent Breast Cancer Research Digest by Dana-Farber
Dana-Farber’s Breast Oncology Center shared a post on X: "Here’s the most recent Breast Cancer…
Oct 1, 2024, 17:18 | Blog
Paolo Tarantino: Feels like yesterday when I first stepped into Dana-Farber Cancer Institute
Paolo Tarantino shared a post on X: "It feels like yesterday when I first stepped…
Oct 1, 2024, 09:29 | Blog
Paolo Tarantino's ESMO24 top 5 breast cancer presentations and takeaway messages
Paolo Tarantino shared a post by Sameh Abdelmalak, Director, Oncology, Educational Partnerships at VuMedi, on X, adding:…
Sep 26, 2024, 16:19 | Blog
Antonio Giordano: Elevating value in cancer care
Antonio Giordano, President of Sbarro Health Research Organization, shared a post on X: ''Elevating value…
Sep 19, 2024, 12:03 | Insight
Trastuzumab deruxtecan in HER2-positive advanced Breast Cancer
Dana-Farber’s Breast Oncology Center shared on X: “Hot off the Press! Trastuzumab deruxtecan in HER2-positive…
Sep 16, 2024, 04:57 | Blog
ESMO24 symposium on the management of oligoprogressive disease - Dana-Farber’s Breast Oncology Center
Dana-Farber’s Breast Oncology Center shared a post on X: ''Don't miss special ESMO24 symposium on…
Sep 16, 2024, 04:57 | Blog
The latest insights on ADCs for HR-Positive, HER2-low metastatic breast cancer - Dana-Farber’s Breast Oncology Center
Dana-Farber’s Breast Oncology Center shared a post on X: ''Paolo Tarantino will discuss the latest…
Sep 10, 2024, 14:58 | Insight
Adjuvant Endocrine Therapy Adherence in patients with breast cancer - Dana-Farber’s Breast Oncology Center
Dana-Farber’s Breast Oncology Center shared a post on X: "New: Effects of Adjuvant Endocrine Therapy-Specific…
Sep 10, 2024, 05:35 | Insight
Ann Partridge will receive the esteemed ESMO24 Award for her contribution to the development of medical oncology
Dana-Farber’s Breast Oncology Center shared on X: "Dr. Ann Partridge will receive the esteemed ESMO24…
Sep 2, 2024, 07:17 | Blog
The 2024 DF/HCC Breast Cancer Program Research Retreat - Dana-Farber’s Breast Oncology Center
Dana-Farber’s Breast Oncology Center shared a post on X: "Register today for the 2024 Dana-Farber/Harvard Cancer…
Aug 31, 2024, 16:48 | Blog
Tess O'Meara: Discussing mIF and machine learning imagine processing on breast cancer with Lajos Pustzai
Tess O'Meara, Hematology/Oncology Fellow at Dana-Farber Cancer Institute, shared a post on X: "Grateful to…
Aug 29, 2024, 03:12 | Blog
Jennifer Bellon on the role of radiation in Ductal Carcinoma In Situ at the annual DCIS Patient Forum
Dana-Farber’s Breast Oncology Center shared on X: "Check out the recording of Dr. Jennifer Bellon,…
Aug 27, 2024, 22:07 | Insight
Sarah Sammons: Expanding telehealth is a very important way to overcome disparities in healthcare access
Sarah Sammons shared a post on X: “Expanding telehealth is a very important way to…
Aug 18, 2024, 06:46 | Blog
The role of Breast Cancer related arm lymphedema in physical functioning among long-term African American breast cancer survivors
Dana-Farber’s Breast Oncology Center posted on X about paper by Sarah Nechuta et al., titled "The…
Aug 13, 2024, 09:53 | Blog
Ann Partridge is the recipient of the 2024 Casty Family Achievement in Mentoring Award
Dana-Farber’s Breast Oncology Center posted on X: "Congratulations to Dr. Ann Partridge who was selected…
Aug 8, 2024, 01:51 | Blog
Chiara Corti: Why Dana-Farber’s Breast Oncology Center is so special
Chiara Corti shared on X: “If a place is as good as the people u…
Aug 7, 2024, 19:44 | Blog
Erica Mayer and Rachel Freedman leading efforts to increase Diversity In Research - Dana-Farber’s Breast Oncology Center
Dana-Farber’s Breast Oncology Center shared a post on X: "At  Dana Farber we are dedicated…
Jul 31, 2024, 11:56 | Insight
Dana-Farber’s Breast Oncology Center's newest Research Digest
Dana-Farber’s Breast Oncology Center shared on X: "Check out the newest Breast Cancer Research Digest…
Jul 31, 2024, 11:22 | Insight
Amal Arnaout discusses potential drug interactions of popular supplements - Dana-Farber’s Breast Oncology Center
Dana-Farber’s Breast Oncology Center shared on X: "Are Supplements Right For Me? Amal Arnaout discusses current…
Jul 25, 2024, 20:48 | Insight
Subcutaneous vs Intravenous Trastuzumab/Pertuzumab in HER2+ Breast Cancer
Dana-Farber’s Breast Oncology Center shared on X: "New in JCO Oncology Practice: Subcutaneous vs Intravenous…
Jul 19, 2024, 09:21 | Blog
Day 2 at the Harvard Breast Cancer Course - Dana-Farber’s Breast Oncology Center
Dana-Farber’s Breast Oncology Center shared a post on X: "Day 2 at the Harvard Breast…
Jul 14, 2024, 06:24 | Blog
Dr. Paolo Tarantino reviewed key ongoing clinical trials at Harvard Breast Cancer Course - Dana-Farber’s Breast Oncology Center
Dana-Farber’s Breast Oncology Center shared a post on X:   . "Dr. Paolo Tarantino reviewed key…
Jul 8, 2024, 15:23 | Blog
Dana-Farber’s Breast Oncology Center - Breast Cancer Prognostic Staging System in AFT-01
Dana-Farber’s Breast Oncology Center shared on X: "Check out this recent publication in Annals of Surgical…
Jun 27, 2024, 15:09 | Blog
Treatment guideline for patients with a history of Breast Cancer who desire pregnancy - Dana-Farber’s Breast Oncology Center
Dana-Farber’s Breast Oncology Center shared on X: "Check out our newest consensus-based treatment guideline offering recommendations…
Jun 25, 2024, 13:37 | Insight
Sacituzumab govitecan with or without pembrolizumab in TNBC
The Dana-Farber’s Breast Oncology Center shared on X: "Dana-Farber’s Breast Oncology Center is leading a…
Jun 21, 2024, 10:34 | Blog
Trial on the use of Cold Caps in preventing hair loss with novel breast cancer therapies - Dana-Farber’s Breast Oncology Center
Dana-Farber’s Breast Oncology Center shared a post on X: “Dana-Farber’s Breast Oncology Center is leading…
Jun 21, 2024, 07:01 | Blog
This week's Breast Cancer Research Digest by Dana-Farber’s Breast Oncology Center
Dana-Farber’s Breast Oncology Center shared a post on X: "Check out this week's Breast Cancer…
Jun 16, 2024, 00:40 | Blog
Register for the Harvard Breast Course - Dana-Farber’s Breast Oncology Center
Dana-Farber’s Breast Oncology Center shared a post on X: "Register for the Harvard Breast Course!…
Jun 12, 2024, 03:50 | Blog
The most recent Breast Cancer Research Digest by Dana-Farber's Breast Oncology Center
Paolo Tarantino shared a post by Dana-Farber's Breast Oncology Center on X, adding the following: “Latest…
Jun 10, 2024, 02:20 | Blog
Paolo Tarantino: Great to welcome Dr. Abeid Athman for a fellowship at Dana-Farber’s Breast Oncology Center!
Paolo Tarantino shared a post on X: “Great to welcome Dr. Abeid Athman from Kenya for…
May 23, 2024, 10:28 | Blog
In a recent interview Dr. Erica Mayer discussed tamoxifen and aromatase inhibitors - Dana-Farber’s Breast Oncology Center
Dana-Farber’s Breast Oncology Center shared a post on X: "In a recent Health Reporter interview…
May 21, 2024, 08:11 | Blog
Clinical trials for patients with Breast Cancer Brain Metastases by Dana-Farber’s Breast Oncology Center
Dana-Farber’s Breast Oncology Center shared on X: “May is Brain Tumor Awarness Month and May 20th…
May 21, 2024, 07:50 | Insight
Daniel Stover: Honored to discuss 4 great breast cancer liquid biopsy abstracts with Heather Parsons at ASCO2024
Daniel Stover, Medical Oncologist and Computational Biologist at Ohio State University Comprehensive Cancer Center, shared…
May 18, 2024, 02:12 | Blog
Paolo Tarantino: Important subanalysis of SOFT/TEXT presented by Otto Metzger
Paolo Tarantino shared on X: "Important subanalysis of SOFT/TEXT presented by Otto Metzger from Dana-Farber’s…
May 17, 2024, 04:08 | Blog
Dana-Farber’s Breast Oncology Center is leading a study for metastatic triple-negative Breast Cancer
Janice Cowden shared a post by Dana-Farber’s Breast Oncology Center on X/Twitter: "If you, or someone…
May 15, 2024, 15:58 | Insight
Guidelines on the use of Bone Modifying Agents in Patients with Breast Cancer - DFCI Breast Oncology Center
Dana-Farber’s Breast Oncology Center shared on X: "Our consensus-based treatment guidelines on the use of…
May 15, 2024, 13:18 | Drugs
Our newest treatment guideline on the use of low-dose Tamoxifen in ER+ DCIS - Dana-Farber’s Breast Oncology Center
Dana-Farber’s Breast Oncology Center shared on X: “Check out our newest treatment guideline on the…
May 14, 2024, 16:00 | Blog
Dr. Sara Tolaney will be the invited discussant for three excellent Breast Cancer trials at ESMO Breast 24 - Dana Farber’s Breast Oncology Center
Dana Farber’s Breast Oncology Center shared a post on X: “Check out the ESMO Breast 24…
May 14, 2024, 07:00 | Insight
The most recent Breast Cancer Research Digest - Dana-Farber’s Breast Oncology Center
Dana-Farber’s Breast Oncology Center shared on X: “Here's the most recent Breast Cancer Research Digest…
May 13, 2024, 09:09 | Blog
Sarah Sammons: Join us for dinner and lively discussion on novel therapies for HR+ MBC
Sarah Sammons shared on X: "Join Aditya Bardia, Virginia Kaklamani and I 6/1 for dinner…
May 5, 2024, 06:21 | Blog
Sara Tolaney discussed the new breast cancer screening guidelines - Dana-Farber’s Breast Oncology Center
Dana-Farber’s Breast Oncology Center shared on their X/Twitter: ''Sara Tolaney discussed the new breast cancer…
May 2, 2024, 14:09 | Blog
The 2nd Annual DCIS Patient Forum - Dana-Farber’s Breast Oncology Center
Dana-Farber’s Breast Oncology Center shared a post on X: “The 2nd Annual Ductal Carcinoma In…
May 2, 2024, 01:48 | Blog
Dana-Farber Breast Oncology Center - Breast Cancer Research Digest
Dana-Farber Breast Oncology Center shared on X: "Here's the Breast Cancer Research Digest - a…
Apr 30, 2024, 05:53 | Blog
Paolo Tarantino: Grateful to e-join SIOM 2024!
Paolo Tarantino shared a post by Sarah Sammons, Medical Oncologist at Dana-Farber’s Breast Oncology Center…
Apr 28, 2024, 16:53 | Blog
Paolo Tarantino: Unmissable editorial on the current status and next steps for studying and treating brain metastases in breast oncology
Paolo Tarantino shared a post by ESMO Open, on X: "Unmissable editorial on the current status…
Apr 28, 2024, 11:58 | Blog
Dana-Farber/Harvard Cancer Center's Initiative to Eliminate Cancer Disparities
Dana-Farber’s Breast Oncology Center shared on their X/Twitter: ''April is National Minority Health Month and…
Apr 25, 2024, 20:14 | Positive
Happy Administrative Professionals Day! - Dana-Farber’s Breast Oncology Center
Quoting Dana-Farber’s Breast Oncology Center on X/Twitter: "Happy Administrative Professionals Day! Today is a reminder…
Apr 13, 2024, 07:26 | Blog
Massimo Cristofanilli: Development of endocrine resistance can be associated with loss of ER expression in CTCs
Massimo Cristofanilli, Professor of Medicine and Director of Breast Medical Oncology, Division of Hematology/Oncology at Weill…
Apr 8, 2024, 14:26 | Drugs
Dana-Farber’s Breast Oncology Center is leading a trial for stage 1 HER2+ Breast Cancer of T-DM1 followed by SQ trastuzumab versus TH
Dana-Farber’s Breast Oncology Center posted on X: "We are leading a randomized Phase 2 trial for…
Apr 7, 2024, 03:41 | Insight
Sarah Sammons: How do we tailor adjuvant therapy without axillary dissection?
Sarah Sammons, Medical Oncologist at Dana-Farber’s Breast Oncology Center, recently shared a post by Massimo…
Mar 16, 2024, 15:39 | Blog
Sarah Sammons: DPYD testing is required before our pharmacy will dispense capecitabine
Sarah Sammons, Breast Medical Oncologist at Dana-Farber’s Breast Oncology Center, shared a post by Vivek Subbiah…
Feb 27, 2024, 15:28 | Blog
Dr. Sara Tolaney discusses Antibody Drug Conjugates - Dana-Farber’s Breast Oncology Center
Quoting Dana-Farber’s Breast Oncology Center on X/Twitter: "Dr. Sara Tolaney discusses Antibody Drug Conjugates in…
Feb 19, 2024, 07:17 | Career
Paolo Tarantino: Honored to be awarded a Terri Brodeur Foundation 2024 Grant
Paolo Tarantino, Medical Oncologist and Research Fellow at Dana-Farber Cancer Institute, shared on X/Twitter: "Honored…
Feb 15, 2024, 18:29 | Blog,Insight
The MARGOT is optimizing preoperative therapy for Stage II-III HER2+ breast cancer - Dana-Farber’s Breast Oncology Center
Dana-Farber’s Breast Oncology Center shared a post on X/Twitter: ''The MARGOT study led by Dana-Farber’s…
Feb 14, 2024, 13:13 | Blog
Chiara Corti: Thanks so much to Gianni Bonadonna Foundation and AIRC Foundation for cancer research for this opportunity
Chiara Corti, Research Fellow at Dana-Farber Cancer Institute, shared a post by Gianni Bonadonna Foundation…
Feb 7, 2024, 14:13 | Blog
Sarah Sammons: When rendering a 2nd opinion that is different from a patients local oncologist, it should be data driven/implementable.
Sarah Sammons, Breast Medical Oncologist at Dana-Farber’s Breast Oncology Center, shared a post on X/Twitter: "To…
Jan 29, 2024, 13:37 | Blog
Sarah Sammons: Learning about Leptomeningeal Disease in Breast Cancer
Sarah Sammons, Breast Medical Oncologist at Dana-Farber's Breast Oncology Center, shared a post on X/Twitter:…
Jan 26, 2024, 17:17 | Societies
30 Posts Not To Miss From ASCO GI24
The ASCO Gastrointestinal Cancer Symposium (GI24) took place from the 18th to the 20th of…
Dec 11, 2023, 11:27 | Insight
Margaret Gatti-Mays: A great option for our patients with TNBC
Margaret Gatti-Mays, Associate Professor in the Division of Medical Oncology at the OSUCCC – James…
12
All: 101 Posts: 1 - 100
Special Coverage